Advertisement · 728 × 90
#
Hashtag
#epalrestat
Advertisement · 728 × 90
Targeting AKR1B1 inhibits metabolic reprogramming to reverse systemic therapy resistance in hepatocellular carcinoma

Targeting AKR1B1 inhibits metabolic reprogramming to reverse systemic therapy resistance in hepatocellular carcinoma

AKR1B1-driven #MetabolicReprogramming sustains #DrugResistance in #HCC, while #epalrestat restores sensitivity—positioning AKR1B1 as both #biomarker and therapeutic target to overcome systemic resistance. @tsinghuauniversity.bsky.social

#STTT: doi.org/10.1038/s413...

0 0 0 0
Post image

Scientists report #MetabolicReprogramming drives #DrugResistance in #HCC; AKR1B1 is a key regulator tied to poor prognosis, while #Epalrestat restores response, marking AKR1B1 as a #biomarker. @tsinghuauniversity.bsky.social

#CoverPage in #STTT: doi.org/10.1038/s413...

2 0 0 0
Post image

Metabolic reprogramming drives #HCC #DrugResistance, with AKR1B1 identified as a key regulator; its inhibition by #Epalrestat restores therapy sensitivity, offering a promising #TherapeuticTarget to overcome resistance. @tsinghuauniversity.bsky.social

#STTT: doi.org/10.1038/s413...

0 0 0 0